Does FOSTAMATINIB Cause Platelet count decreased? 804 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 804 reports of Platelet count decreased have been filed in association with FOSTAMATINIB (TAVALISSE). This represents 12.6% of all adverse event reports for FOSTAMATINIB.
804
Reports of Platelet count decreased with FOSTAMATINIB
12.6%
of all FOSTAMATINIB reports
8
Deaths
312
Hospitalizations
How Dangerous Is Platelet count decreased From FOSTAMATINIB?
Of the 804 reports, 8 (1.0%) resulted in death, 312 (38.8%) required hospitalization, and 1 (0.1%) were considered life-threatening.
Is Platelet count decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FOSTAMATINIB. However, 804 reports have been filed with the FAERS database.
What Other Side Effects Does FOSTAMATINIB Cause?
Diarrhoea (904)
Product dose omission issue (711)
Off label use (680)
Hospitalisation (403)
Platelet count (375)
Drug ineffective (340)
Fatigue (332)
Blood pressure increased (314)
Death (307)
Headache (237)
What Other Drugs Cause Platelet count decreased?
LENALIDOMIDE (7,491)
NIRAPARIB (4,102)
ELTROMBOPAG OLAMINE (3,419)
RUXOLITINIB (3,028)
RITUXIMAB (2,404)
VENETOCLAX (2,367)
DEXAMETHASONE (2,321)
PALBOCICLIB (2,277)
CYCLOPHOSPHAMIDE (1,894)
RIBAVIRIN (1,701)
Which FOSTAMATINIB Alternatives Have Lower Platelet count decreased Risk?
FOSTAMATINIB vs FOSTEMSAVIR TROMETHAMINE
FOSTAMATINIB vs FOTEMUSTINE
FOSTAMATINIB vs FRAMYCETIN
FOSTAMATINIB vs FREMANEZUMAB
FOSTAMATINIB vs FREMANEZUMAB-VFRM